Fig. 5

Network meta-analysis reporting risk ratio (RR) for renal outcomes in CKD patients. SGLT-2 sodium-glucose cotransporter 2, GLP-1 RA glucagon-like peptide-1 receptor agonist, CKD chronic kidney disease